Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer [Phase 2]
A Phase 2 trial of cetuximab in combination chemotherapy for patients with stage III-IV resectable oropharyngeal cancer has completed, with …
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study [Phase 2]
Phase II trial evaluating Kanglaite to reduce radiotherapy toxicity in head and neck cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy  [Phase 2, Phase 3]
A clinical trial update for a multimodality-adapted dose modification approach in head and neck cancer undergoing radiation therapy (Phase 2…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical study evaluating camrelizumab in combination with neoadjuvant chemotherapy for operable locally advanced head and neck squa…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects [Phase 2]
Phase 2 trial update on ALD518 for reducing oral mucositis in head and neck cancer; study terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer [Phase 3]
Phase 3 trial comparing reduced radiotherapy with paclitaxel/cisplatin vs standard radiotherapy with 5-fluorouracil/cisplatin in locally adv…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery [Phase 4]
Phase 4 trial update on continuous popliteal block for microvascular free flap reconstruction in head and neck surgery; study completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating Rebamipide Liquid for preventing chemoradiotherapy-induced oral mucositis in head and neck cancer patients has comp…
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy [Phase 3]
Phase 3 trial evaluating vortioxetine for depression associated with radiation injuries in patients with head and neck cancer undergoing rad…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma:The POTENTIAL Study [Phase 2]
Phase II multicenter trial evaluating post-operative concurrent chemoradiotherapy with weekly cisplatin and tislelizumab for high-risk head …
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating concomitant chemoradiotherapy with weekly docetaxel and cisplatin for locally advanced head and neck cancer has com…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen [Phase 2]
Phase 2 trial investigating NC-6004 plus pembrolizumab in head and neck cancer after platinum failure is underway but with unknown current s…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 study evaluating chemoradiation plus pembrolizumab for locally advanced laryngeal squamous cell carcinoma has completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes [Phase 2]
Phase II open-label multicenter trial of cabazitaxel in patients with recurrent or metastatic head and neck cancer after failure of cisplati…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating induction chemotherapy followed by chemoradiotherapy in head and neck cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer [Phase 4]
Phase 4 trial update on CKI for oral mucositis caused by radiotherapy in head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx [Phase 3]
Phase 3 trial evaluating radiation therapy with or without combination chemotherapy for advanced cancer of the oropharynx or hypopharynx.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy plus radiation therapy in head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Single-arm Phase II Study of NDURE for Patients With HNC [NA]
Phase II single-arm trial of NDURE in patients with cancer of the head and neck has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer [NA]
A completed clinical trial investigating neuromodulation-based pain control in patients undergoing definitive chemoradiotherapy for head and…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Web-Based Multimedia Intervention for Head and Neck Cancer Patients [NA]
A completed clinical trial evaluating a web-based multimedia intervention for patients with head and neck cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC) [Phase 2]
Phase 2 trial investigating radiation therapy with cetuximab for advanced head and neck squamous cell carcinoma was terminated; results post…
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer [NA]
A completed pilot trial evaluating image-guided adaptive radiotherapy for head and neck/oropharyngeal cancer with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203) [Phase 1, Phase 2]
Phase 1/2 study of epacadostat plus durvalumab in selected advanced solid tumors completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® [Phase 2]
Phase 2 trial updating autologous therapeutic vaccination against solid cancers using intratumoral Hiltonol shows completed status.